Hancock Whitney’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-132,653
Closed -$1.38M 784
2020
Q1
$1.38M Buy
132,653
+30,829
+30% +$387K 0.05% 311
2019
Q4
$1.63M Sell
101,824
-17,726
-15% -$271K 0.05% 348
2019
Q3
$2.2M Sell
119,550
-1,536
-1% -$30K 0.07% 281
2019
Q2
$2.38M Sell
121,086
-22,700
-16% -$462K 0.08% 272
2019
Q1
$3.29M Sell
143,786
-6,749
-4% -$147K 0.11% 241
2018
Q4
$3.03M Buy
150,535
+21,505
+17% +$445K 0.1% 246
2018
Q3
$2.81M Buy
+129,030
New +$2.87M 0.08% 277

Other funds holding ANGO

Hancock Whitney's ANGO Position: Q2 2020 in Review

Hancock Whitney sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 132,653 shares — an estimated $1.38M sold.

Hancock Whitney first reported a position in ANGO in Q3 2018 and held it in 7 quarters. The position peaked at $3.29M in Q1 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Hancock Whitney reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Hancock Whitney sold 132,653 AngioDynamics shares in Q2 2020, an estimated $1.38M.
  • Hancock Whitney first reported a position in AngioDynamics in Q3 2018 and held it in 7 quarters.
  • Hancock Whitney's AngioDynamics position peaked at $3.29M in Q1 2019.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Hancock Whitney's 13F filing for Q2 2020, filed 30 Jul 2020.